Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census studyArticle Published on 2022-10-272022-11-15 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 진단, [키워드] adjusted age Antibody test Asymptomatic category Chemiluminescent assay Comorbidity conducted confidence interval country COVID-19 COVID-19 vaccination determine effective enrolled General population HCW healthcare worker hospital hospital management IgG IgG antibody IgG test implementation increased risk Infection lowest mild symptoms Odds ratio over positive positive PCR test positive SARS-CoV-2 PCR predictor Prevalence preventive measure SAR-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid sensitivity Seroprevalence Sex staff Symptoms university was performed [DOI] 10.1371/journal.pone.0267619 PMC 바로가기
Rapid Increase in Suspected SARS-CoV-2 Reinfections, Clark County, Nevada, USA, December 2021Article Published on 2022-10-012022-11-15 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] acute respiratory syndrome affected age calculated Clark collected coronavirus coronavirus disease COVID-19 defined demographic group demographic groups Disease surveillance groups Health Health authority incidence increase initial Local Native Nevada omicron Omicron variant positive PCR test Positive test proportion Public raise Rapid Reinfection remained respiratory infections SARS SARS-CoV-2 SARS-CoV-2 variant severe acute respiratory syndrome coronavirus 2 Surveillance Suspected the SARS-CoV-2 United States USA variant viruses women zoonoses zoonoses. [DOI] 10.3201/eid2810.221045 PMC 바로가기
Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo)Research article Published on 2022-08-262022-10-05 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), SARS, 진단, [키워드] Administered Adults aerobic age asymptomatic infection base Blood BMI cardiovascular complications cholesterol cohort study Concentration control group COVID-19 COVID-19 group criteria defined Diagnosis diagnostic dyslipidaemia enrolled fatigue Fatigue scale female finding Follow-up force funding Health healthy higher risk individual Intensive IQR Laboratory Laboratory parameters LDL longitudinal cohort study male management median men metabolic disorder negative RT-PCR neurological no symptoms non-hospitalised organ systems outcomes participant Participants persistent physical polymorphism positive positive PCR test presenting Prevalence Psychological public health quantified questionnaire Registered renal reported reproductive RT-PCR test SARS-CoV-2 SARS-COV-2 infection Serologically serologically positive significant difference study groups Switzerland Symptom the median threshold were excluded with COVID-19 [DOI] 10.1016/S1473-3099(22)00449-2 [Article Type] Research article
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study중증 급성 호흡기 증후군 코로나 바이러스 2의 지속 기간 및 델타 변이에 대한 자연 면역 및 보호: 후향적 코호트 연구Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus Against Analysis Chain Reaction coronavirus coronavirus 2 COVID-19 defined Delta delta variant dominant Duration Effectiveness infected patient Infection initial natural natural immunity Patient PCR polymerase chain polymerase chain reaction positive positive PCR test Positive test Primary outcome protection Protective protective effectiveness Reinfection reinfection. respiratory retrospective cohort study SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 shown subsequent symptomatic disease tested vaccination Vaccinations Vaccine [DOI] 10.1093/cid/ciab999 PMC 바로가기 [Article Type] Article
Testing for coronarvirus disease 2019 before cardiac surgery-safe outcome of infected patients감염된 환자의 심장 수술 안전한 결과 전에 코로나바이러스 질병 2019에 대한 테스트Article Published on 2022-08-242022-09-11 Journal: Journal of Cardiothoracic Surgery [Category] SARS, 치료기술, [키워드] airway Body body mass body mass index cardiac Cardiac surgery chronic obstructive chronic obstructive pulmonary disease coronavirus disease Coronavirus disease 2019 COVID-19 diabetes Diabetes Mellitus diagnosed disease Ejection fraction female gender hospital Hospital staff index infected patient less mass nasopharynx negative test not differ obstructive pulmonary disease operation outbreak outcome pandemic Patient patients patients with COVID-19 PCR PCR testing performed positive COVID-19 positive PCR test postoperative preoperative Preoperative PCR testing. pulmonary disease reduced significantly surgery surgical swabs Symptom Testing Transmission undergo ventricular ventricular ejection virus was recorded with COVID-19 [DOI] 10.1186/s13019-022-01960-1 PMC 바로가기 [Article Type] Article
Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment리툭시맙 치료 환자에서 SARS-CoV-2 감염 후 90일 동안 지속되는 발열 및 PCR 양성: 후기 항바이러스 치료 1례Case Reports Published on 2022-08-112022-09-11 Journal: Viruses [Category] SARS, 진단, 치료제, [키워드] Antiviral treatment antivirals B cell B cell immune responses benefit Day defined diagnostic dominant Dyspnea early treatment feasible Fever full recovery high fever Hospitalized human long-term infection hyperinflammation Hypoxemia immune immune responses Immunocompromised Immunocompromised patients immunosuppressive immunosuppressive therapy infusion interval low-grade viral replication lower airway lower airways lung infiltrate lung infiltrates Mild mild to moderate moderate monoclonal monoclonal antibodies monoclonal antibody multiple sclerosis Patient patients PCR persistent persistent fever positive PCR test post infection Prophylactic receiving reduced reported Respiratory failure rituximab rituximab. SARS-CoV-2 SARS-COV-2 infection sensitivity serum severe respiratory failure Symptom therapy Treatment treatment approach treatment approaches Viral viral replication [DOI] 10.3390/v14081757 PMC 바로가기 [Article Type] Case Reports
SARS-CoV-2 serological assay and viral testing: a report of professional football settingSARS-CoV-2 혈청학적 분석 및 바이러스 테스트: 프로 축구 환경 보고서Article Published on 2022-07-012022-09-11 Journal: Postgraduate medical journal [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] alternative method association collected comprehension COVID-19 COVID-19 disease COVID-19 testing diagnosing diagnosis of SARS-CoV-2 IgG IgG antibodies IgG antibody IgM inconsistency Infection limitations male management nasopharyngeal swabs Negative PCR participant PCR PCR test PCR-positive Peripheral blood peripheral blood samples positive positive PCR test recovered patients SARS-CoV-2 SARS-CoV-2 IgM SARS-COV-2 infection SARS-CoV-2 PCR test serological Serological assay serological assays Serological testing Serological tests seropositive significantly higher Sports Medicine sports medicine. subjects Swab Symptom symptomatic symptomatic case symptomatic cases tested the disease the SARS-CoV-2 [DOI] 10.1136/postgradmedj-2021-140176 PMC 바로가기 [Article Type] Article
Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID장기간 코로나바이러스에 감염된 혈청 음성 환자의 이전 SARS-CoV-2 감염의 증거Article Published on 2022-07-012022-09-11 Journal: EBioMedicine [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute illness antibody assay Cambridge Cohort Consensus COVID COVID-19 illness Definition detectable Diagnosis diagnostic Evidence evidence of IFN-γ IL-2 Immunity infected with SARS-CoV-2 Innovation Long Long COVID Medical Research Council MRC NHSBT NIHR non-hospitalised Patient patients peptides positive PCR test Research reveal SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 peptide SARS-CoV-2 peptides seronegative patient seronegative patients supported Symptoms T cell T cell response T cell responses T cell. T cells tested Trust United Kingdom Wellcome Trust [DOI] 10.1016/j.ebiom.2022.104129 PMC 바로가기 [Article Type] Article
Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis알파 및 델타 SARS-CoV-2 변종 생성 시간: 역학 분석Article Published on 2022-05-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI Alpha alpha and delta variants Alpha variant analysed Analysis assumed B.1.1.529 B.1.617.2 Contact tracing Council credible interval decrease delta variant Delta variants determine dominant dominant variant effective Effectiveness Engineering epidemiological faster Generation Generation time genomic sequencing household Households index case Infection Innovation intrinsic Isolation less mathematical occur participant Participants positive PCR test posterior probability recruited reflect responsible SARS-CoV-2 SARS-CoV-2 variant Science security susceptible susceptible individual susceptible individuals Transmissibility Transmission Transmission model transmissions variant virus was used [DOI] 10.1016/S1473-3099(22)00001-9 PMC 바로가기 [Article Type] Article
Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers실생활에서 코로나백의 약화 효과: 의료 종사자를 대상으로 한 후향적 코호트 연구Article Published on 2022-04-202022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted Alpha Alpha variant association booster dose booster doses clinical trials conducted CoronaVac COVID-19 COVID-19 disease COVID-19 infection COVID-19 infections COVID-19 vaccine Cox regression defined demonstrated determine dominant dose doses Effectiveness follow-up period groups Health care Health care worker health care workers Inactivated vaccine incidence rate İstanbul positive PCR test rate ratio receive receiving reduce retrospective cohort study SARS-COV-2 infection second dose test result the vaccine Turkey university hospital vaccination Vaccine vaccine effectiveness. variant variants were used [DOI] 10.1016/j.vaccine.2022.03.032 PMC 바로가기 [Article Type] Article